Overview

Study Evaluating Potential Pharmacokinetic (PK) Interaction Between Lecozotan and Digoxin

Status:
Completed
Trial end date:
2008-09-01
Target enrollment:
Participant gender:
Summary
Primary: To evaluate the effects of multiple doses of lecozotan SR on the PK profile of a single dose of digoxin in healthy adult subjects. Secondary: To assess the safety and tolerability of the coadministration of lecozotan SR and digoxin.
Phase:
Phase 1
Details
Lead Sponsor:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Digoxin